The DOI matches its Crossref record; 28 of the 30 references it cites were found in a registry or an index.
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts
Abstract
Clinical, imaging, and pathological studies in multiple sclerosis have generally emphasized the relative preservation of axons in comparison with myelin. Recent evidence, however, demonstrates that axonal loss is also significant, affects long tracts such as the corticospinal and sensory tracts and relates closely to functional disability. Accordingly, the distribution and extent of this axonal loss is the focus of the current investigation. Post-mortem material of 55 multiple sclerosis patients and 32 matched controls was used to examine quantitatively the population of axons in the corticospinal tracts from the medulla to the lumbar spinal cord and the sensory tracts from the lumbar to the upper cervical spinal cord. Myelin- and axon-stained sections have been prepared to estimate the notional area and axon density, respectively of both tracts. Our results indicate that in the corticospinal tracts there is a significant reduction of the area and axon density at all levels investigated in multiple sclerosis cases when compared with controls. In contrast, the sensory tracts in multiple sclerosis cases showed a significant reduction in area and axon density only in the upper regions of the spinal cord. As has been found with MRI plaque load and T2 burden, correlations of axonal loss with duration of disease were not strong. Of the fibres lost in multiple sclerosis, we have found that small fibres (<3 microm2) seem to be particularly affected, with large fibres remaining relatively preserved in both the corticospinal and sensory tracts. In multiple sclerosis, axonal loss is widespread, and its extent is tract specific and size selective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spinal cord pathology is an important determinant of permanent neurological disability with cardinal characteristics being inflammatory demyelination, synaptic, neuronal and axonal loss.6, 7, 8, 9, 10, 11”
From Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology? (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regarding the NSF maps, neurofilament antigenicity can be negatively affected by formalin fixation,6 which may be at least in part responsible for some of the heterogeneity shown in our neurofilament immunolabeling.”
From Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology? (2017) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T. P., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 935
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Spinal cord atrophy and disability in multiple sclerosis
Losseff, N. A., Webb, S. L., O’Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.3.701 · Cited by 642
Multiple Sclerosis: A Reappraisal
(1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb110785.x · Cited by 568
Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons
Yin, X., Crawford, T. O., Griffin, J. W., Tu, P., Lee, V. M. ‐., Li, C. C., Roder, J., & Trapp, B. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01953.1998 · Cited by 491
Evangelou, N. (2000) · Brain · doi:10.1093/brain/123.9.1845 · Cited by 416
Davie, C., Barker, G., Webb, S., Tofts, P., Thompson, A. J., Harding, A., Mcdonald, W., & Miller, D. (1995) · Brain : a journal of neurology · doi:10.1093/brain/118.6.1583 · Cited by 381
Flagged first, then by citations
2 of the 30 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 793±901.
- Charcot M. Histologie de la sclerose en plaques. Gaz Hop (Paris) 1868; 141: 554±8.
- Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000a; 47: 391±5.
- Scherer S. Axonal pathology in demyelinating diseases. Ann Neurol 1999; 45: 6±7.
Cited by
Sorted by citations
Items 101–200 of 255
Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis
Kozin, M. S., Кулакова, О. Г., & Favorova, O. O. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918070052 · Cited by 53
KEARNEY, H. F., Yiannakas, M. C., Samson, R. S., Wheeler‐Kingshott, C. A. M. G., Ciccarelli, O., & Miller, D. H. (2014) · Brain · doi:10.1093/brain/awu171 · Cited by 51
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology
DeLuca, G. C., Alterman, R., Martin, J. L., Mittal, A., Blundell, S., Bird, S., Beale, H., Hong, L. S., & Esiri, M. M. (2013) · Brain · doi:10.1093/brain/awt031 · Cited by 52
Self-citationValsasina, P., Aboulwafa, M., Preziosa, P., Messina, R., Falini, A., Comi, G., Filippi, M., & Rocca, M. A. (2018) · Radiology · doi:10.1148/radiol.2018172311 · Cited by 50
Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms
Levin, M. C., Gardner, L. A., Douglas, J. N., Meyers, L., Lee, S., & Shin, Y. (2014) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s54391 · Cited by 52
Lema, A., Bishop, C., Malik, O., Mattoscio, M., Ali, R., Nicholas, R. S., Muraro, P. A., Matthews, P. M., Waldman, A. D., & Newbould, R. D. (2016) · Journal of Neuroimaging · doi:10.1111/jon.12377 · Cited by 51
A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis
Furby, J., Hayton, T., Altmann, D., Brenner, R., Chataway, J., Smith, K. J., Miller, D., & Kapoor, R. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5563-y · Cited by 47
Markianos, M., Koutsis, G., Evangelopoulos, M., Mandellos, D., Karahalios, G., & Sfagos, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05750.x · Cited by 46
Distribution of mitochondria along small‐diameter myelinated central nervous system axons
Edgar, J. M., McCulloch, M. C., Thomson, C. E., & Griffiths, I. R. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21672 · Cited by 44
Lisak, R. P., Nedelkoska, L., Studzinski, D. M., Bealmear, B., Xu, W., & Benjamins, J. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.010 · Cited by 46
Spinal Cord Imaging in Multiple Sclerosis
Tench, C. R., Morgan, P. S., Jaspan, T., Auer, D. P., & Constantinescu, C. S. (2005) · Journal of Neuroimaging · doi:10.1177/1051228405283292 · Cited by 45
KEARNEY, H. F., Miszkiel, K., Yiannakas, M. C., Altmann, D. R., Ciccarelli, O., & Miller, D. H. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515604905 · Cited by 44
Role of n‐type voltage‐dependent calcium channels in autoimmune optic neuritis
Gadjanski, I., Boretius, S., Williams, S. K., Lingor, P., Knöferle, J., Sättler, M. B., Fairless, R., Hochmeister, S., Sühs, K., Michaelis, T., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21668 · Cited by 44
Disseminated encephalomyelitis in children
Tenembaum, S. N. (2008) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.12.018 · Cited by 43
Liptak, Z., Berger, A. M., Sampat, M. P., Charil, A., Felsovalyi, O., Healy, B. C., Hildenbrand, P. G., Khoury, S. J., Weiner, H. L., Bakshi, R., et al. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1162 · Cited by 43
Double diffusion encoding and applications for biomedical imaging
Henriques, R. N., Palombo, M., Jespersen, S. N., Shemesh, N., Lundell, H., & Ianuș, A. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108989 · Cited by 46
Chaves, A. R. D. A., Wallack, E. M., Kelly, L. P., Pretty, R. W., Wiseman, H. D., Chen, A. P., Moore, C. S., Stefanelli, M., & Ploughman, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.005 · Cited by 42
Primary progressive multiple sclerosis takes centre stage
Matthews, P. M. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.044263 · Cited by 39
Lu, J.-Q., Fan, Y., Mitha, A., Bell, R., Metz, L., Moore, G. R. W., & Yong, W. V. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e318196e905 · Cited by 31
James, R., Hillis, J. M., Adorján, I., Gration, B., Mundim, M. V., Iqbal, A. J., Majumdar, M., Yates, R. L., Richards, M. M. H., Goings, G. E., et al. (2015) · Glia · doi:10.1002/glia.22906 · Cited by 39
Self-citationAntigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and Peptides
da Fontoura, P. P., Garren, H., & Steinman, L. (2005) · International Reviews of Immunology · doi:10.1080/08830180500379655 · Cited by 38
Jackson, S. J., Lee, J., Nikodemova, M., Fabry, Z., & Duncan, I. D. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a41d23 · Cited by 38
Immunopathology of multiple sclerosis
Fox, E. (2004) · Neurology · doi:10.1212/wnl.63.12_suppl_6.s3 · Cited by 38
Size Distribution Imaging by Non-Uniform Oscillating-Gradient Spin Echo (NOGSE) MRI
Shemesh, N., Álvarez, G. A., & Frydman, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133201 · Cited by 36
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis.
Rovaris, M., Gallo, A., Falini, A., Benedetti, B., Rossi, P., Comola, M., Scotti, G., Comi, G., & Filippi, M. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.898 · Cited by 34
Protecting axons in multiple sclerosis
Wilkins, A., & Scolding, N. J. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508091370 · Cited by 36
Song, X., Li, D., Qiu, Z., Su, S., Wu, Y., Wang, J., Liu, Z., & Dong, H. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101426 · Cited by 36
Chaves, A. R. D. A., Snow, N. J., Alcock, L. R., & Ploughman, M. (2021) · Brain Sciences · doi:10.3390/brainsci11030384 · Cited by 45
Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy
Bagnato, F. R., Gauthier, S. A., Laule, C., Moore, G. R. W., Bove, R. M., Cai, Z., Cohen‐Adad, J., Harrison, D. M., Klawiter, E. C., Morrow, S. A., et al. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12700 · Cited by 37
Olfactory Pathology in Central Nervous System Demyelinating Diseases
DeLuca, G. C., Joseph, A., George, J., Yates, R. L., Hamard, M., Hofer, M., & Esiri, M. M. (2015) · Brain Pathology · doi:10.1111/bpa.12209 · Cited by 46
Self-citationSynaptic Loss in Multiple Sclerosis Spinal Cord
Petrova, N., Nutma, E., Carassiti, D., Newman, J. R., Amor, S., Altmann, D. R., Baker, D., & Schmierer, K. (2020) · Annals of Neurology · doi:10.1002/ana.25835 · Cited by 33
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy
Iodice, R., Carotenuto, A., Dubbioso, R., Cerillo, I., Santoro, L., & Manganelli, F. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.04.026 · Cited by 33
Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability
Wang, E., Dimova, N., Sperle, K., Huang, Z., Lock, L. F., McCulloch, M. C., Edgar, J. M., Hobson, G. M., & Cambi, F. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.001 · Cited by 30
Andersson, M., Pizzolato, M., Kjer, H. M., Skodborg, K. F., Lundell, H., & Dyrby, T. B. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118718 · Cited by 27
Güngör, F., Tarakçı, E., Özdemir, Z., & Soysal, A. (2021) · Multiple Sclerosis Journal · doi:10.1177/13524585211012202 · Cited by 31
Optical coherence tomography monitoring and diagnosing retinal changes in multiple sclerosis
Mehmood, A., Ali, W., Song, S., Din, Z. U., Guo, R., Shah, W., Ilahi, I., Yin, B., Yan, H., Zhang, L., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2302 · Cited by 29
What role should spinal cord MRI take in the future of multiple sclerosis surveillance?
Rocca, M. A., Preziosa, P., & Filippi, M. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1739524 · Cited by 29
Grussu, F., Schneider, T., Yates, R. L., Zhang, H., Wheeler-Kingshott, C. A. M. G., DeLuca, G. C., & Alexander, D. C. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.08.002 · Cited by 26
Self-citationRojas-Vite, G., Coronado‐Leija, R., Narvaez, O., Ramírez-Manzanares, A., Marroquin, J. L., Noguez-Imm, R., Aranda, M. L., Scherrer, B., Larriva-Sahd, J. A., & Concha, L. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116013 · Cited by 25
Imaging Spinal Cord Damage in Multiple Sclerosis
Rocca, M. A., Hickman, S. J., Bö, L., Agosta, F., Miller, D., Comi, G., & Filippi, M. (2005) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2005.tb00327.x · Cited by 26
Zhou, Z., Tong, Q., Zhang, L., Ding, Q., Lu, H. J., Jonkman, L. E., Yao, J., He, H., Zhu, K., & Zhong, J. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117313 · Cited by 28
Bundle-Specific Axon Diameter Index as a New Contrast to Differentiate White Matter Tracts
Baraković, M., Girard, G., Schiavi, S., Romascano, D., Descoteaux, M., Granziera, C., Jones, D. K., Innocenti, G. M., Thiran, J., & Daducci, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.646034 · Cited by 25
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE
Moreno, M. A., Guo, F., Ko, E. M., Bannerman, P. G. C., Soulika, A. M., & Pleasure, D. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.12.014 · Cited by 25
Mapping axonal density and average diameter using non-monotonic time-dependent gradient-echo MRI
Nunes, D., Cruz, T. L., Jespersen, S. N., & Shemesh, N. (2017) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2017.02.017 · Cited by 24
Cahill, L. S., Zhang, M. A., Ramaglia, V., Whetstone, H., Sabbagh, M. P., Yi, T. J., Woo, L. A., Przybycien, T. S., Moshkova, M., Zhao, F. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915141116 · Cited by 24
Edgar, J. M., & Griffiths, I. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374709-9.00005-5 · Cited by 25
Alturkustani, M. A., Keith, J. L., Hazrati, L., Rademakers, R., & Ang, L.-C. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000168 · Cited by 24
A longitudinal MRI study of cervical cord atrophy in multiple sclerosis
Valsasina, P., Rocca, M. A., Horsfield, M. A., Copetti, M., & Filippi, M. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7754-z · Cited by 23
Early prognosis of multiple sclerosis
Swanton, J. K., Fernando, K., & Miller, D. H. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00015-7 · Cited by 25
Development of type I/II oligodendrocytes regulated by teneurin-4 in the murine spinal cord
Hayashi, C., Suzuki, N., Takahashi, R., & Akazawa, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65485-0 · Cited by 24
Lee, H., Tian, Q., Sheft, M., Coronado‐Leija, R., Ramos‐Llordén, G., Abdollahzadeh, A., Fieremans, E., Novikov, D. S., & Huang, S. Y. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5087 · Cited by 24
Li, G., Esiri, M. M., Ansorge, O., & DeLuca, G. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-20 · Cited by 22
Self-citationDisease evolution in multiple sclerosis
Ebers, G. C. (2006) · Journal of Neurology · doi:10.1007/s00415-006-6002-y · Cited by 22
Bitirgen, G., Akpınar, Z., Uca, A. U., Özkağnıcı, A., Petropoulos, I. N., & Malik, R. A. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.13.37 · Cited by 21
Manogaran, P., Vavasour, I., Borich, M., Kolind, S., Lange, A., Rauscher, A., Boyd, L., Li, D. K. B., & Traboulsee, A. (2016) · Multiple Sclerosis · doi:10.1177/1352458515579441 · Cited by 27
Kamiya, K., Hori, M., Miyajima, M., Nakajima, M., Suzuki, Y., Kamagata, K., Suzuki, M., Arai, H., Ohtomo, K., & Aoki, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103842 · Cited by 20
Normalized Upper Cervical Spinal Cord Atrophy in Multiple Sclerosis
Song, F., Yi, H., Yin, H. J., Ge, Y., Wei, G., Chang, Y., & Zhao, H. (2008) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00222.x · Cited by 20
Lin, T., Sun, P., Hallman, M. J., Hwang, F. C., Wallendorf, M., Ray, W. Z., Spees, W. M., & Song, S. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.6016 · Cited by 20
Moore, C. S., Hebb, A. L. O., Blanchard, M. M., Crocker, C. E., Liston, P., Korneluk, R. G., & Robertson, G. S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.030 · Cited by 20
Sinnecker, T., Granziera, C., Wuerfel, J. T., & Schlaeger, R. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0504-7 · Cited by 18
Sajic, M., Ida, K. K., Canning, R., Gregson, N. A., Duchen, M. R., & Smith, K. J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1094-8 · Cited by 19
Liu, Z., Li, Y., Zhang, J., Elias, S. B., & Chopp, M. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.08.013 · Cited by 16
The role of hereditary spastic paraplegia related genes in multiple sclerosis
DeLuca, G. C., Ramagopalan, S. V., Cader, M. Z., Dyment, D. A., Herrera, B. M., Orton, S. M., Degenhardt, A., Pugliatti, M., Sadovnick, A. D., Sotgiu, S., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0505-4 · Cited by 15
Self-citationLevin, M. C., Lee, Gardner, Shin, Douglas, & Groover (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s38353 · Cited by 15
Construction of a rat spinal cord atlas of axon morphometry
Saliani, A., Zaimi, A., Nami, H., Duval, T., Stikov, N., & Cohen‐Adad, J. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116156 · Cited by 15
Bergaglio, T., Luchicchi, A., & Schenk, G. J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.610295 · Cited by 16
Neurodegeneration and Demyelination in the Multiple Sclerosis Spinal Cord
Mahajan, K. R., Herman, D. E., Zheng, Y., Androjna, C., Thoomukuntla, B., Ontaneda, D., Nakamura, K., & Trapp, B. D. (2025) · Neurology · doi:10.1212/wnl.0000000000210259 · Cited by 14
Sampat, M. P., Berger, A. M., Healy, B. C., Hildenbrand, P. G., Vass, J., Meier, D., Chitnis, T., Weiner, H. L., Bakshi, R., & Guttmann, C. R. G. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1659 · Cited by 14
Levin, M. C., Lee, S., Gardner, L. A., Shin, Y., Douglas, J. N., & Salapa, H. E. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.07.005 · Cited by 13
Romascano, D., Baraković, M., Rafael‐Patiño, J., Dyrby, T. B., Thiran, J., & Daducci, A. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28053 · Cited by 14
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis
Ramagopalan, S. V., DeLuca, G. C., Morrison, K., Herrera, B. M., Dyment, D. A., Orton, S. M., Bihoreau, M.-T., Degenhardt, A., Pugliatti, M., Sadovnick, A. D., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.02.003 · Cited by 13
Self-citationMillet, V., Marder, M., & Pasquini, L. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.028 · Cited by 15
Spinal cord α-synuclein deposition associated with myoclonus in patients with MSA-C
Hwang, J., Bank, A. M., Mortazavi, F., Oakley, D. H., Frosch, M. P., & Schmahmann, J. D. (2019) · Neurology · doi:10.1212/wnl.0000000000007949 · Cited by 12
Immunological Aspects of Axon Injury in Multiple Sclerosis
Howe, C. L. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6_5 · Cited by 11
Biomarkers in multiple sclerosis: an update for 2014.
Fernández, Ó., Martinꝉ, R., Rovira, À., Llufriú, S., Vidal‐Jordana, Á., Fernández-Sánchez, V. E., Alvarez-Cermeño, J. C., Izquierdo, G., Arroyo-González, R., Antigüedad, A. R., et al. (2014) · PubMed · Cited by 11
Challenges in multiple sclerosis; how to define occurence of progression
Brinar, V. V., & Barun, B. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.09.017 · Cited by 12
Edgar, J. M., & Griffiths, I. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396460-1.00007-x · Cited by 13
Rinker, J. R., Meador, W. R., & King, P. H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04528 · Cited by 11
Holzknecht, C., & Röhl, C. (2009) · NeuroImmunoModulation · doi:10.1159/000243082 · Cited by 11
Magnetic resonance imaging correlates of neuro‐axonal pathology in the MS spinal cord
Schmierer, K., & Miquel, M. E. (2018) · Brain Pathology · doi:10.1111/bpa.12648 · Cited by 12
Neuronopathy in the Motor Neocortex in a Chronic Model of Multiple Sclerosis
Burns, T., Miers, L. A., Xu, J., Man, A. J., Moreno, M. A., Pleasure, D., & Bannerman, P. G. C. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000058 · Cited by 9
Carboxymethyllysine and carboxyethyllysine in multiple sclerosis patients
Damasiewicz-Bodzek, A., Labuz-Roszak, B. M., Kumaszka, B., & Tyrpień-Golder, K. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.95654 · Cited by 9
Alghamdi, A. J. (2023) · Brain Sciences · doi:10.3390/brainsci13040622 · Cited by 8
Can T 2 -Spectroscopy Resolve Submicrometer Axon Diameters?
Kaden, E., & Alexander, D. C. (2013) · Lecture notes in computer science · doi:10.1007/978-3-642-38868-2_51 · Cited by 8
Brasanac, J., & Chien, C. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1151531 · Cited by 7
Craner, M., & Fugger, L. H. (2011) · Nature Medicine · doi:10.1038/nm0411-423 · Cited by 7
Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance
Lucchinetti, C. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-36003-4_12 · Cited by 7
Zhang, Z.-W., Qin, X.-Y., Che, F., Xie, G., Shen, L., & Bai, Y.-Y. (2015) · Genetics and Molecular Research · doi:10.4238/2015.october.28.17 · Cited by 7
Teixeira, L. B. C., Hoeve, J. N. V., Mayer, J. A., Dubielzig, R. R., Smith, C. M., Radcliff, A. B., & Duncan, I. D. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19871 · Cited by 7
Ovacık, U., Tarakçı, E., & Özdemir, Z. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104944 · Cited by 6
Mechanisms of Disease Progression
Wilkins, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_4 · Cited by 6
Lee, C., Huisinga, J. M., Choi, I.-Y., LYNCH, S. G., & Lee, P. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.11.004 · Cited by 6
Huang, S., Pisa, M., Guerrieri, S., Costa, G. D., Comı, G., & Leocani, L. (2023) · Brain Communications · doi:10.1093/braincomms/fcad249 · Cited by 6
Foxley, S., Karczmar, G. S., & Takahashi, K. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27338 · Cited by 6
Edwards, E. M., Stanley, J. A., Daugherty, A. M., Lynn, J., Borich, M. R., & Fritz, N. E. (2022) · Journal of Neuroimaging · doi:10.1111/jon.13064 · Cited by 5
Neuron–oligodendrocyte interaction in neuroinflammation
Itoh, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12227 · Cited by 5
Multiple sclerosis findings in the spinal cord
Edwards, L. J., Tench, C. R., Gilmore, C., Evangelou, N., & Constantinescu, C. S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.9.1203 · Cited by 5
Sexual wellbeing in Parkinson’s disease
Giovannoni, G. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.043927 · Cited by 36
Moreno‐García, A., Serrat, R., Julio‐Kalajzić, F., Bernal‐Chico, A., Baraibar, A. M., Matute, C., Marsicano, G., & Mato, S. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16305 · Cited by 4
Abnormal Spinal Cord Magnetic Resonance Signal: Approach to the Differential Diagnosis
Morales, H., & Betts, A. M. (2016) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2016.05.003 · Cited by 4
Metadata
- Authors
- DeLuca, G. C.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- DeLuca, G. C.
- ORCID
- DeLuca, G. C.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-26
- Volume
- 127
- Issue
- 5
- Pages
- 1009-1018
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1999110803
- Cited by
- 255
- References
- 30
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 8 · 2020: 14 · 2019: 12 · 2018: 13 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 14 · 2013: 12 · 2012: 12
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- University of Oxford
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Keywords
- multiple sclerosis, axonal loss, corticospinal tract, axon density, myelin, spinal cord, disease duration, functional disability, postmortem pathology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Axons, Female, Humans, Image Processing, Computer-Assisted, Male, Middle Aged, Multiple Sclerosis, Pyramidal Tracts, Spinal Cord, Staining and Labeling, Case-Control Studies, Ganglia, Sensory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review